Pricing

Log inSign up

Stoke Therapeutics

96 people · 0 jobs
‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Biotechnology

Headquarters

Bedford, United States

Employees

51-200

Links

Org chart

Edward M. Kaye
CEO & Director
Collapse
Stephen J. Tulipano
CFO
Dawn Kalmar
Chief Of Corporate Affairs & Strategic Partnerships
Barry S. Ticho
Chief Medical Officer
Jonathan Allan
General Counsel
KP
Kimberly Parkerson
Senior Vice President, Head Of Neurology Clinical Development
Jason Hoitt
Chief Patient Officer
Joan Wood
CHRO
Katherine Pare Lefeber
Vice President, Strategy
Malini Viswanathan Ph.D
Vice President Portfolio and Alliance Management
JB
Jessica Blumstein
Vice President, Global Market Access And Distribution

Board & advisors

SH
Seth L. Harrison
Chairman
AK
Adrian Krainer
Co-Founder & Director
Jennifer Burstein
Director
Arthur Levin
Director
Garry E. Menzel
Director
Julie Anne Smith
Director
Arthur Tzianabos
Director

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

170 followers

Regeneron

143 followers

Illumina

81 followers

Agilent Technologies

88 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

Explore companies